• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[墨西哥一家三级儿科医院中过敏反应的病因及治疗]

[Causes and treatment of anaphylaxis in a Mexican third-level pediatric hospital].

作者信息

Castaño-Jaramillo Lina, Toledo-Salinas Carla, Mendoza David

机构信息

Universidad CES, Facultad de Medicina, Medellin, Antioquia, Colombia.

出版信息

Rev Alerg Mex. 2021 Jul-Sep;68(3):160-164. doi: 10.29262/ram.v68i3.904.

DOI:10.29262/ram.v68i3.904
PMID:34634845
Abstract

OBJECTIVE

To clinically characterize the events of anaphylaxis in a third-level pediatric hospital.

METHODS

1148 clinical records were reviewed. Eventually, the information of 35 events of anaphylaxis in 20 patients was analyzed; three of them had multiple episodes of anaphylaxis.

RESULTS

The median age for the anaphylactic episodes was 11 years (Interquartile range 10 years, Q1 = 5, Q3 = 15), predominantly in adolescents between the ages of 12 and 17 years, and there was a slight predominance in women. The most frequent clinical manifestations were cutaneous (86%), followed by respiratory (83%), cardiovascular (74%), and gastrointestinal (46%) alterations. Cardiac arrest was documented in three episodes; however, no anaphylaxis-related deaths were reported. The main triggers for anaphylaxis were food (34%), medications (29%), allergen-specific immunotherapy (14%), and latex (11%). In patients with perioperative anaphylaxis, the clinical behavior was severe. Epinephrine was administered in 27 out of the 35 events (77%), but only in 11 cases it was the first-line treatment. Systemic corticosteroids were the most frequently used treatment, followed by epinephrine and antihistamines.

CONCLUSIONS

The use of epinephrine, which is the mainstay of the treatment, is suboptimal; with a preferred use of second-line medications like corticosteroids. Clear protocols for the diagnosis and treatment of anaphylaxis, as well as continuous education of health personnel, are necessary.

摘要

目的

对一家三级儿童医院的过敏反应事件进行临床特征分析。

方法

回顾了1148份临床记录。最终,分析了20例患者中35起过敏反应事件的信息;其中3例有多次过敏反应发作。

结果

过敏反应发作的中位年龄为11岁(四分位间距为10岁,Q1 = 5,Q3 = 15),主要发生在12至17岁的青少年中,女性略占优势。最常见的临床表现为皮肤症状(86%),其次是呼吸道症状(83%)、心血管症状(74%)和胃肠道症状(46%)。有3次发作记录到心脏骤停;然而,未报告与过敏反应相关的死亡病例。过敏反应的主要诱因是食物(34%)、药物(29%)、变应原特异性免疫治疗(14%)和乳胶(11%)。围手术期发生过敏反应的患者,临床症状严重。35起事件中有27起(77%)使用了肾上腺素,但只有11例将其作为一线治疗药物。全身用皮质类固醇是最常用的治疗药物,其次是肾上腺素和抗组胺药。

结论

作为主要治疗药物的肾上腺素使用并不理想;更倾向于使用皮质类固醇等二线药物。需要制定明确的过敏反应诊断和治疗方案,以及对医护人员进行持续教育。

相似文献

1
[Causes and treatment of anaphylaxis in a Mexican third-level pediatric hospital].[墨西哥一家三级儿科医院中过敏反应的病因及治疗]
Rev Alerg Mex. 2021 Jul-Sep;68(3):160-164. doi: 10.29262/ram.v68i3.904.
2
Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data.管理过敏反应:肾上腺素、抗组胺药和皮质类固醇:跨越加拿大过敏反应登记处的 10 多年数据。
Ann Allergy Asthma Immunol. 2023 Dec;131(6):752-758.e1. doi: 10.1016/j.anai.2023.08.606. Epub 2023 Sep 7.
3
Evaluation of treatment and long-term management of anaphylaxis in pediatric departments of Greece: a 2-year nationwide survey.希腊儿科部门中过敏反应的治疗和长期管理评估:一项为期 2 年的全国性调查。
Allergol Immunopathol (Madr). 2024 May 1;52(3):8-16. doi: 10.15586/aei.v52i3.1032. eCollection 2024.
4
Anaphylaxis in Children: Experience of 485 Episodes in 1,272,482 Patient Attendances at a Tertiary Paediatric Emergency Department from 2007 to 2014.儿童过敏反应:2007年至2014年在一家三级儿科急诊科1,272,482次患者就诊中的485次发作经历
Ann Acad Med Singap. 2016 Dec;45(12):542-548.
5
Emergency department visits for food allergy in Taiwan: a retrospective study.台湾地区因食物过敏而前往急诊科就诊的情况:一项回顾性研究。
Pediatr Neonatol. 2014 Aug;55(4):275-81. doi: 10.1016/j.pedneo.2013.11.006. Epub 2014 Mar 17.
6
Anaphylaxis treated in a Canadian pediatric hospital: Incidence, clinical characteristics, triggers, and management.加拿大一家儿科医院对过敏反应的治疗:发病率、临床特征、诱因及管理。
J Allergy Clin Immunol. 2013 Sep;132(3):739-741.e3. doi: 10.1016/j.jaci.2013.06.016. Epub 2013 Jul 27.
7
Anaphylaxis management in the pediatric emergency department: opportunities for improvement.儿科急诊科的过敏反应管理:改进的机会
Pediatr Emerg Care. 2010 Feb;26(2):71-6. doi: 10.1097/PEC.0b013e3181ce2e1c.
8
Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes.纽约市儿科急诊部的过敏反应:触发因素、治疗方法和结果。
J Allergy Clin Immunol. 2012 Jan;129(1):162-8.e1-3. doi: 10.1016/j.jaci.2011.09.018. Epub 2011 Oct 22.
9
The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: clinical signs, severity, and therapeutic agents.日本围手术期过敏反应的流行病学研究,一项前瞻性全国性研究:临床体征、严重程度和治疗药物。
Br J Anaesth. 2023 Jul;131(1):170-177. doi: 10.1016/j.bja.2023.02.023. Epub 2023 Mar 24.
10
[Treatment of anaphylactic shock].[过敏性休克的治疗]
Ther Umsch. 2001 May;58(5):325-8. doi: 10.1024/0040-5930.58.5.325.

引用本文的文献

1
Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.在全国性被动流行病学监测计划背景下对 SARS-CoV-2 疫苗的过敏反应。
J Clin Immunol. 2022 Nov;42(8):1593-1599. doi: 10.1007/s10875-022-01350-1. Epub 2022 Aug 17.